Geopolitical Tensions Rise as Detainee Allegations Surface in Gaza Flotilla Incident EON Resources Inc Set to Present at Planet MicroCap Las Vegas 2026 Consumer Price Index Rises 38 Annually in April Exceeding Expectations Oil Prices Edge Higher as USIran Peace Talks Progress Slowly Strait of Hormuz Disruption Persists Dropbox CEO Drew Houston Plans Transition to Executive Chairman After 19 Years Reddit Shares Slide Nearly 6 After Meta Launches Standalone Forum App GTX Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Operational Performance MTB Q1 2026 Earnings Earnings Beat Estimates as Net Interest Income Holds Steady Shattuck Labs Q1 2026 Earnings EPS Surprise Drives Positive Market Reaction CMBM Q3 2024 Earnings EPS Surprise Beat Amidst Operational Restructuring DUO Q2 2021 Earnings Massive Earnings Miss as EPS Plunges Deeply Negative Universal Health Realty Income Trust UHT Q1 2026 Earnings Solid EPS Amidst Modest Market Response MMD Shares Advance 152 Approaching Key Resistance Amid Improved Sentiment Urban One UONEK Surges 7 as Media Stock Consolidates Above Key Support TAL Education Group TAL Holds Near Support After Modest Gain PTC Therapeutics PTCT Slips 140 as Biotech Sector Faces Selling Pressure Bogota Financial Corp BSBK Slips 118 as Stock Tests Key Support Near 800 Wholesale Inflation Surges to 6 in April Marking Biggest Annual Gain Since 2022 CubeSmart CUBE Q1 2026 Earnings EPS Beats Estimates Amid Stable Operations Rice Acquisition Corporation 3 KRSP Holds Steady at 1045 Amidst Low Volume Consolidation Vaxcyte Q1 2026 Earnings EPS Misses Estimates Amid PreCommercial Investment Phase CMS Energy CMSD Q1 2026 Earnings Modest EPS Beat Amid Steady Utility Operations REPX Q1 2026 Earnings Massive EPS Miss Sends Stock Lower NPO Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher Enhabit Inc EHAB Q4 2025 Earnings EPS Narrowly Misses Estimates Stock Edges Higher UEC Q1 2026 Earnings NarrowerThanExpected Loss as Uranium Developer Advances Projects C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution